Gentian Diagnostics AS (GENT) — Cash Flow Reinvestment Rate
Gentian Diagnostics AS (GENT) has a Cash Flow Reinvestment Rate of 0.25x as of December 2025, reinvesting Nkr10.76 Million (capex Nkr10.76 Million ) from operating cash flow of Nkr42.59 Million. See GENT free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gentian Diagnostics AS Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for Gentian Diagnostics AS across 4 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Gentian Diagnostics AS.
Annual Cash Flow Reinvestment Rate for Gentian Diagnostics AS (2013–2025)
Year-by-year capital reinvestment analysis for Gentian Diagnostics AS. See Gentian Diagnostics AS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.25x | Nkr10.76 Million | Nkr42.59 Million | Nkr10.76 Million | ▼ -84.5% |
| 2024 | 1.63x | Nkr21.90 Million | Nkr13.46 Million | Nkr10.95 Million | ▲ +147.8% |
| 2023 | 0.66x | Nkr10.15 Million | Nkr15.46 Million | Nkr4.49 Million | ▼ -54.2% |
| 2013 | 1.44x | Nkr3.49 Million | Nkr2.43 Million | Nkr3.49 Million | — |